Average Co-Inventor Count = 9.75
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (38 from 1,970 patents)
38 patents:
1. 9873701 - Heterocyclic compounds and their uses
2. 9718803 - Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
3. 9611261 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
4. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
5. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
6. 9493459 - Azetidine and piperidine compounds useful as PDE10 inhibitors
7. 9376450 - Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors
8. 9303028 - Azetidine and piperidine compounds useful as PDE10 inhibitors
9. 9296734 - Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
10. 9174992 - Heterobicyclic compounds
11. 9090593 - Bicyclic compounds as Pim inhibitors
12. 9085576 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
13. 8957073 - Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
14. 8952037 - Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
15. 8946230 - Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors